Your browser doesn't support javascript.
loading
TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma.
Schaettler, Maximilian O; Desai, Rupen; Wang, Anthony Z; Livingstone, Alexandra J; Kobayashi, Dale K; Coxon, Andrew T; Bowman-Kirigin, Jay A; Liu, Connor J; Li, Mao; Bender, Diane E; White, Michael J; Kranz, David M; Johanns, Tanner M; Dunn, Gavin P.
Afiliación
  • Schaettler MO; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Desai R; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Wang AZ; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Livingstone AJ; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Kobayashi DK; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Coxon AT; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Bowman-Kirigin JA; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Liu CJ; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.
  • Li M; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bender DE; Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
  • White MJ; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Kranz DM; Biochemistry, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
  • Johanns TM; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Dunn GP; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA gpdunn@mgh.harvard.edu.
J Immunother Cancer ; 11(2)2023 02.
Article en En | MEDLINE | ID: mdl-36808076
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inmunoterapia Adoptiva / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inmunoterapia Adoptiva / Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos